SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023492
Filing Date
2016-08-09
Accepted
2016-08-09 08:21:41
Documents
58
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20160630.htm 10-Q 2178109
2 EX-10.36 rgnx-ex1036_117.htm EX-10.36 1368991
3 EX-31.1 rgnx-ex311_8.htm EX-31.1 16687
4 EX-31.2 rgnx-ex312_9.htm EX-31.2 16719
5 EX-32.1 rgnx-ex321_6.htm EX-32.1 10297
  Complete submission text file 0001564590-16-023492.txt   8431418

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgnx-20160630.xml EX-101.INS 1563092
7 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20160630.xsd EX-101.SCH 41456
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20160630_cal.xml EX-101.CAL 49456
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20160630_def.xml EX-101.DEF 167824
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20160630_lab.xml EX-101.LAB 350043
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20160630_pre.xml EX-101.PRE 267149
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 161816145
SIC: 2836 Biological Products, (No Diagnostic Substances)